+1-858-251-2010 info@nucleusbiologics.com
  • LinkedIn
  • Facebook
  • Twitter
  • LinkedIn
  • Facebook
  • Twitter
0 Items
Nucleus Biologics
  • Home
  • Products
    • Physiologix™ XF SR
    • Vitronectin XF™
    • Media and Buffers
    • NB-ROC™ SF
    • CMRL Media
  • Formulation Services
  • Quality
  • NB-Lux
  • NB-AIR
  • Krakatoa™
  • Education
    • Education
    • Technical Documentation
  • Our Purpose
    • Serving Science
    • Curing Disease
    • Leadership Team
    • Board of Directors
  • FAQ
  • Contact
    • Contact Us
    • Careers
Select Page
Nucleus Biologics Unveils Expanded Facility in San Diego, New Cleanrooms to Support Cell Culture Media Manufacturing

Nucleus Biologics Unveils Expanded Facility in San Diego, New Cleanrooms to Support Cell Culture Media Manufacturing

by Brad N. Taylor, Ph.D. | Sep 23, 2022

(San Diego, CA – September 23, 2022) — Nucleus Biologics, The Cell Performance Company™, an industry-leading provider of small lot custom cell culture media, celebrated the opening of its newest building on their San Diego campus and the unveiling of additional...
Nucleus Biologics Obtains ISO 13485:2016 Certification

Nucleus Biologics Obtains ISO 13485:2016 Certification

by Brad N. Taylor, Ph.D. | Aug 23, 2022

ISO 13485:2016 certification demonstrates Nucleus Biologics’ commitment to maintaining premium quality standards. (San Diego, CA – August 23, 2022) Nucleus Biologics, The Cell Performance Company™, the industry-leading provider of small lot custom media for the cell...
Nucleus Biologics Announces Krakatoa™, Aiming to Reinvent the Cell Culture Media Industry

Nucleus Biologics Announces Krakatoa™, Aiming to Reinvent the Cell Culture Media Industry

by Brad N. Taylor, Ph.D. | Feb 28, 2022

Krakatoa’s point of use media manufacturing reduces greenhouse gas emissions by 65% per unit of media produced. (San Diego, CA – February 28, 2022) Nucleus Biologics, The Cell Performance Company™, is proud to announce the launch of Krakatoa™, an innovative,...
Cytiva and Nucleus Biologics join forces to accelerate development of custom cell media for cell and gene therapies

Cytiva and Nucleus Biologics join forces to accelerate development of custom cell media for cell and gene therapies

by Brad N. Taylor, Ph.D. | Jan 20, 2022

Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and...
Nucleus Biologics Joins Cell Manufacturing Research Initiative

Nucleus Biologics Joins Cell Manufacturing Research Initiative

by Dr. Alyssa Master | Sep 20, 2018

For immediate release Nucleus Biologics Joins Cell Manufacturing Research Initiative SAN DIEGO – SEPTEMBER 20, 2018 – Nucleus Biologics is pleased to announce it has joined the new NSF Engineering Research Center for Cell Manufacturing Technologies, known as CMaT. The...
« Older Entries

Search

Tags

cell culture media Cell Therapy cgmp Concierge gmp IPSCs Islet cells iso Krakatoa Media Manufacturing MSCs NB-AIR NB-ROC NB Lux physiologix Press Release Reproducibility scale-up Stem Cells sustainability T Cell Vitronectin webinar XF
  • NB-Lux
  • NB-AIR
  • Krakatoa™
  • Products
  • Education
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • LinkedIn
  • Facebook
  • Twitter
©2022 Nucleus Biologics, LLC. All Rights Reserved.